🇺🇸

US SEC Filing Intelligence

· daily

US Corporate Distress Financial Stress SEC Filings — August 17, 2026

The digest focuses on two US public companies showing significant distress signals, with one filing new and one carried over. Nexalin Technology reveals a critical, high-materiality (9/10) delisting risk from a Nasdaq stockholders' equity deficiency ($1.5M vs. $2.5M requirement) compounded by an existing bid price appeal, posing an immediate threat to liquidity and market access. Conversely, Cloudastructure, with a mixed sentiment filing (7/10), shows a classic growth-at-a-loss profile: subscription revenue surged 164% YoY and now dominates the mix (62%), but total revenue grew only 13% as hardware sales collapsed, and operating losses widened to $2.7M. While Nexalin presents a clear liquidation or restructuring risk, Cloudastructure's path to profitability is uncertain given rising expenses and cash burn. No positive sector themes emerge; both cases highlight heightened capital market scrutiny on small-cap, cash-burning entities. The aggregate period-over-period trend is one of deteriorating financial health and elevated delisting risk.

2 high priority 2 total filings
· daily

Global High-Priority Regulatory Events — August 17, 2026

This digest covers 46 filings from August 17, 2026, dominated by a wave of corporate distress and strategic realignment. The most critical theme is a surge in insolvencies and defaults, with Pradhin Limited, Vivimed Labs, Simbhaoli Sugars, TV Vision, and Dharan Infra-EPC all undergoing CIRP, while Mangalam Drugs shows a prolonged 10-month bank default. Concurrently, a major consolidation is underway in the real estate and behavioral health sectors, highlighted by the $70B merger of AvalonBay and Equity Residential into Vivmark Residential, and Universal Health Services' acquisition of Talkspace. Several companies are also facing Nasdaq delisting pressures, including Dermata Therapeutics, Nexalin Technology, and Talkspace (post-acquisition). On the positive side, there is significant M&A activity in the industrial and infrastructure space, with Lloyds Engineering and Lloyds Enterprises acquiring controlling stakes in SISCOL, and Manipal Health Enterprises expanding its hospital network. The data reveals a bifurcated market: capital is flowing into strategic consolidations and growth acquisitions, while heavily indebted or operationally challenged companies are entering resolution processes.

46 high priority 46 total filings
· daily

US SEC Filings Daily Market Digest — August 17, 2026

Today's filings reveal a market bifurcated between aggressive M&A and capital markets activity and a wave of operational distress. Notable M&A includes TTM Technologies' $1.1B acquisition of Epiq Solutions and LogicMark's merger with Langham Project, while several companies (Wellgistics, Ming Shing, Cosan) show severe revenue declines or losses. Late filings (NT 10-Q) from M2i Global, FDCTECH, Duos, and IWAC signal potential accounting or operational issues. Insider activity is limited, but Dreamland's CEO increased her stake, and Cosan's CFO departure adds to its restructuring narrative. Capital allocation trends show a mix of warrant exercises (Dogness), convertible note raises (Wellgistics), and a SPAC IPO (Gravity Acquisition). Sector themes include a focus on liquidity and restructuring in energy/industrial, continued biotech volatility, and passive ETF dominance in 13F filings. Key catalysts include Centene's CFO transition, Interactive Strength's special meeting, and Bleichroeder's business combination vote.

17 high priority 33 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 17, 2026

Today's filings in the Consumer Discretionary sector are dominated by insider activity, with a clear pattern of profit-taking at Carvana (two directors sold ~$2.2M combined) and a notable CFO sale at DoorDash, while Aptiv's director purchase stands out as a bullish signal. Ulta Beauty's board appointment of a seasoned retail CEO signals strategic focus on specialty retail expertise and potential digital/omnichannel growth. No operational or financial guidance was provided in these filings, so the digest focuses on insider conviction and governance signals. The sector shows mixed sentiment: insider selling at high valuations (Carvana, DoorDash) versus insider buying at depressed levels (Aptiv). The absence of period-over-period financial data limits trend analysis, but the insider activity patterns offer actionable intelligence on management and director sentiment.

6 high priority 6 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 17, 2026

The five filings from S&P 500 Healthcare constituents for August 17, 2026, reveal a sector in a period of strategic transition and governance refresh, with no major financial surprises. The most significant development is Centene's planned CFO transition, which introduces key-person risk during a period of reaffirmed guidance, while CVS Health's board refresh signals a strategic pivot toward data and analytics. Medtronic's proxy filing confirms a routine AGM with standard proposals, offering no new operational insights. The filings are notably devoid of insider trading activity or capital allocation changes, suggesting a quiet period for most companies. Overall, the digest points to a sector focused on leadership stability and board composition rather than aggressive financial maneuvers, with limited immediate catalysts for stock movement.

4 high priority 1 medium 5 total filings
· daily

US Earnings Financial Results SEC Filings — August 17, 2026

The 35 filings for August 17, 2026, present a deeply bifurcated market landscape. While a handful of large-cap industrial and technology companies (Lumentum, Sandisk, Harmonic) are executing powerful turnarounds with triple-digit revenue growth and massive margin expansion, the vast majority of filers are micro-cap or pre-revenue firms burning cash and facing existential liquidity crises. A dominant theme is the prevalence of non-cash charges (impairments, debt extinguishment, and crypto-related losses) that are obscuring deteriorating underlying operations. For instance, Lumentum's $6.9B net loss is entirely due to a one-time debt extinguishment, masking a fundamentally sound business. Conversely, companies like ALT5 Sigma and XCF Global are seeing real collateral damage from collapsing revenue and unsustainable capital structures. The SPAC sector continues to be a dead zone, with most vehicles (Welsbach, Copley, Twelve Seas) failing to find deals and relying solely on trust interest income to show a profit. Insider trading data is sparse, with no significant open-market buys or sells flagged across the filings. The primary takeaway is that investors must dig past headline net income to assess cash flow, revenue quality, and the sustainability of balance sheets, as the gap between "reported earnings" and "financial health" has rarely been wider. Cash flow warnings are abundant, with 5+ companies (DocGo, NexMetals, NanoVibronix, Mitesco, Charli e 's ) showing signs of cash burn that will require near-immediate capital raises.

35 high priority 35 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 17, 2026

This digest of 10 DEF 14A proxy filings reveals a mixed picture for the US equity market, with a clear divergence between established, cash-rich companies executing strategic transformations and smaller, cash-strapped firms resorting to dilutive measures. FedEx stands out as a positive outlier, having successfully spun off FedEx Freight and seeing its stock hit all-time highs, a testament to its strategic execution. Conversely, a cluster of micro-cap and special purpose acquisition companies (SPACs), including Interactive Strength, Twin Vee PowerCats, and BPGC Acquisition Corp., are showing signs of distress, seeking shareholder approval for reverse stock splits and business combination extensions to stave off delisting or liquidation. A key cross-cutting theme is the prevalence of 'mixed' sentiment, particularly at FedEx, which acknowledges a volatile global environment despite its operational success, and the negative sentiment surrounding BPGC Acquisition Corp., which faces a high risk of liquidation. From a governance perspective, several companies, including HeartCore Enterprises and Coda Octopus Group, maintain a combined CEO/Chairman structure, a point of focus for activist investors. The forward-looking data points to a catalyst-rich period in late September and October 2026, with annual meetings scheduled for FedEx, Medtronic, and Inhibitor Therapeutics, which will be critical for assessing shareholder sentiment on executive compensation and strategic direction.

10 high priority 10 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 17, 2026

The IPO pipeline on August 17, 2026, is dominated by secondary offerings rather than primary capital raises, with two of three filings (Alliance Laundry Holdings and Andersen Group) being secondary sales by existing stockholders, signaling potential insider monetization or exit events. Andersen Group shows a sharp operational turnaround, swinging from a net loss of $130.2M in FY2025 to profitability of $7.6M in H1 2026, driven by 19% YoY revenue growth and strong client retention (70% of revenue from clients engaged >3 years). VS Trust's filing for six new 3x leveraged ETFs introduces high-risk, high-volatility products into the market, with a clear warning that investors could lose their entire principal in a single day, reflecting a trend toward complex, leveraged crypto and commodity exposure. Period-over-period comparisons reveal a mixed pipeline: revenue growth is robust at Andersen (15% YoY in FY2025, 19% in H1 2026), but profitability remains volatile, while Alliance Laundry and VS Trust offer no historical financials, limiting trend analysis. The lack of insider trading activity in any filing is notable, suggesting either quiet periods ahead of offerings or a lack of management conviction. Capital allocation data is absent across all three, indicating these are early-stage filings with no dividend or buyback history. The key market implication is that the IPO pipeline is currently a vehicle for shareholder liquidity rather than growth capital, which may dampen investor enthusiasm for new issues.

3 high priority 3 total filings
· daily

US Executive Officer Management Changes SEC — August 17, 2026

The August 17, 2026, executive and director change filings reveal a period of significant leadership turnover, with high-profile CEO and CFO transitions at several key companies, often tied to strategic shifts or governance issues. A notable pattern is the 'revolving door' between companies, exemplified by Dr. Raj Talluri leaving Enovix to become CEO of Kulicke & Soffa, creating a direct leadership arbitrage opportunity. While many changes are routine succession planning, several carry high materiality due to sudden departures (L3Harris CEO, Tivic Health CEO) or strategic implications (CVS adding a data/AI expert, Bakkt appointing a new CFO). The data shows a clear trend of boards refreshing with specialized expertise in data analytics, AI, and cybersecurity, while several companies reaffirmed guidance, signaling stability amidst leadership flux. The most actionable insights come from the Enovix-Kulicke & Soffa leadership swap, the L3Harris governance crisis, and the LiveRamp shareholder vote rejecting executive compensation, which all present distinct investment signals.

29 high priority 29 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 17, 2026

The August 17, 2026, batch of 29 filings reveals a period of significant leadership churn across US public companies, with a notable cluster of high-materiality CEO and CFO transitions. Key themes include a 'revolving door' for top executives, with Raj Talluri moving from Enovix to Kulicke & Soffa, and a wave of CFO changes at major firms like Centene, Aon, and Park Aerospace. While most transitions appear orderly with long handover periods, the sudden departures at L3Harris (CEO for conduct) and Tivic Health (CEO termination) inject risk. A strong positive signal is the overwhelming shareholder approval (92.23% quorum) of the LiveRamp-Publicis Groupe merger, despite a non-binding 'say-on-pay' rejection. The data shows a clear emphasis on board refreshment with specialized expertise in data/analytics (CVS Health), real estate (NNN REIT), and cybersecurity (Horizon Bancorp), pointing to a strategic evolution in corporate governance.

29 high priority 29 total filings
· daily

USA Insider Trading Pulse — August 17, 2026

Today's insider trading pulse reveals a stark divergence between aggressive insider buying in small/mid-cap healthcare and technology names versus systematic insider selling at Sea Ltd and Similarweb. The most concentrated buying event is at EDAP TMS SA, where six insiders—including the CEO, CFO, GC, and three directors—collectively purchased $490K at $4.75, signaling strong conviction at a potential inflection point. On Holding AG saw its two top executives invest a combined $3.98M at $30.67, a rare and highly bullish signal from founders. Conversely, Sea Ltd's top five executives sold $3.8M via 10b5-1 plans, while Similarweb's CEO executed a $2.02M sale-and-exercise combo. Webster Financial's filings are dominated by routine tax-withholding share surrenders following equity awards, which are non-directional. The period-over-period data from the enriched filings shows no revenue or margin trends, as these are transaction filings, but the insider activity patterns themselves are the key signal: clusters of buying at beaten-down prices (EDAP, Aclarion, ACCESS Newswire) suggest bottom-fishing, while large-scale selling at Sea Ltd and Camtek warrants caution.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 17, 2026

The US M&A landscape on August 17, 2026, is defined by transformative mega-deals, a flurry of SPAC extension filings, and strategic divestitures. The completion of the AvalonBay/Equity Residential merger creates Vivmark Residential, a $70B EV real estate behemoth, signaling a trend toward consolidation for scale and structural earnings growth. In behavioral health, Universal Health Services' acquisition of Talkspace establishes a comprehensive virtual-to-inpatient care continuum, positioning the combined entity to capture a larger share of the mental health market. Conversely, a wave of SPACs (Ribbon, FutureTech II, Future Vision II) are seeking deadline extensions, highlighting ongoing challenges in finding viable targets, while Pinnacle Acquisition Corp. sees insider accumulation (sponsor, CEO, and affiliate) despite no imminent deal. Braemar Hotels' sale of the Pier House Resort for $190M improves its financial profile, turning a FY2025 loss into a pro forma gain. However, Helix Acquisition Corp. III faces a Nasdaq deficiency notice for failing to meet the 300 total holders requirement, adding to SPAC sector uncertainty. Overall, the digest reveals a bifurcated market: strong strategic M&A with clear synergies versus struggling SPACs needing more time and facing regulatory hurdles.

11 high priority 11 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 17, 2026

The overnight filing period from August 16-17, 2026, reveals a market dominated by significant corporate actions, including a major $1.1B acquisition by TTM Technologies, a SPAC merger update for Bleichroeder Acquisition Corp. II, and a strategic restructuring at Cosan S.A. involving a NYSE delisting and asset spin-off. Financial distress is a prominent theme, with several companies (Wellgistics Health, Ming Shing Group, M2i Global) reporting sharp revenue declines and widening losses, while others like FDCTECH show dramatic turnarounds post-acquisition. Insider activity is mixed, with a significant insider purchase at Dreamland Ltd signaling confidence, contrasted by CEO termination at Tivic Health and CFO departures at Centene and Cosan. Capital allocation trends are defensive, with Cosan aggressively deleveraging and several companies raising cash through convertible notes and warrant exercises. The 13F filings reveal a strong institutional preference for large-cap tech and passive ETFs, with notable biotech concentration in some hedge fund portfolios. Overall, the market is bifurcated between companies executing transformative deals and those struggling with operational headwinds, creating both risks and opportunities for investors.

17 high priority 33 medium 50 total filings
· daily

New Federal Contractors — August 16, 2026

This digest covers a single, large civilian contract: a $198.5 million firm-fixed-price award from the Smithsonian Institution to Universal Protection Service, Limited Partnership for unarmed guard services through 2026. The contract is 100% civilian, with no defense exposure, and represents a long-duration, low-tech, labor-intensive service agreement. The highest-conviction signal is neutral, reflecting the revenue visibility from an 8-year term but offset by high margin risk from fixed pricing in a high-cost labor market (Washington, DC). The key risk is wage inflation eroding profitability under the fixed-price structure, with no set-aside or competitive moat to buffer the contractor.

1 total filings
· daily

Contract Deobligations Alert — August 16, 2026

This digest covers a single, large civilian contract: a $198.5 million firm-fixed-price award from the Smithsonian Institution to Universal Protection Service, Limited Partnership for unarmed guard services through 2026. With zero defense-related contracts in the period, the digest is entirely civilian-focused, highlighting a stable but low-growth sector. The highest-conviction signal is the neutral rating, as the contract's long duration provides revenue visibility but its fixed-price nature and high-cost Washington, D.C. labor market create significant margin risk. The key risk to monitor is wage inflation in the D.C. metro area, which could compress margins on this labor-intensive contract.

1 total filings
· daily

Contract Option Exercises — August 16, 2026

This digest covers a single, large civilian contract option exercise totaling $198.5 million, with zero defense exposure. The dominant theme is a long-duration, fixed-price security services contract awarded to Universal Protection Service, Limited Partnership by the Smithsonian Institution. The highest-conviction signal is a neutral-to-bearish risk assessment due to the firm-fixed-price structure in a high-cost labor market (Washington, DC), which creates margin vulnerability to wage inflation. The key risk is that this is a labor-intensive, low-tech contract with no competitive moat, offering stable but low-growth revenue visibility with significant execution risk under fixed pricing.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — August 16, 2026

The period's sole mega contract ($100M+) is a $198.5 million civilian award from the Smithsonian Institution to Universal Protection Service, Limited Partnership for unarmed guard services. With zero defense-related obligations in the stream, the period reflects minimal direct exposure to Pentagon budget priorities. The contract's firm-fixed-price nature and full-and-open competition create margin risk in a high-cost labor market, offset by exceptional long-duration revenue visibility through 2026-2027. The neutral signal strength (6/10) and lack of any bullish or bearish calls underscore a low-conviction, cash-flow-stability story rather than a growth catalyst.

1 total filings
· daily

High-Value Federal Grants ($5M+) — August 16, 2026

The sole high-value grant analyzed for August 16, 2026, is a $198.5 million firm-fixed-price contract awarded to Universal Protection Service, Limited Partnership by the Smithsonian Institution for unarmed guard services through 2026. This is a purely civilian award with no defense exposure, reflecting stable but low-growth agency funding for security services. The highest-conviction signal is neutral, as the long-duration revenue visibility is offset by significant margin risk from fixed pricing in a high-cost labor market (Washington, DC). Key risks include wage inflation and the absence of set-aside protections, which could pressure profitability over the contract's 8+ year term.

1 total filings